| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K03536150 |
| PharmacoGx | BRD-K03536150 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LYSMD1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CKAP5 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | EIF4EBP2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | EED | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | CLK2 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | TMED9 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | CCNE2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | DCUN1D2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | COQ7 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | TRPV2 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
